TMO EBITDA Growth
Thermo Fisher Scientific · EBITDA Growth
TMO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported1.49%period ending
TMO TTM EBITDA YoY % (45.12% → 1.49%)
Year-over-year change
High-resolution chart · PNG
TMO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 1.4912% | |
| -0.9932% | |
| -2.2321% | |
| -3.1215% | |
| -3.3735% | |
| 1.2859% | |
| 5.1133% | |
| 5.934% | |
| 10.8939% | |
| 4.6024% | |
| -6.4897% | |
| -6.0915% | |
| -11.8631% | |
| -8.9174% | |
| -0.1755% | |
| -8.8767% | |
| -6.7228% | |
| -0.6376% | |
| 18.3869% | |
| 56.9412% | |
| 90.0573% | |
| 72.7611% | |
| 43.8844% | |
| 17.2635% | |
| -2.4918% | |
| 9.4753% | |
| 13.3473% | |
| 16.5544% | |
| 23.9769% | |
| 19.9624% | |
| 22.6129% | |
| 26.5787% | |
| 23.2225% | |
| 19.2503% | |
| 15.3669% | |
| 12.2219% | |
| 7.4114% | |
| 7.4846% | |
| 8.4342% | |
| 5.5369% | |
| 5.8002% | |
| 3.5304% | |
| 1.6636% | |
| 11.8195% | |
| 23.4289% | |
| 41.3483% | |
| 51.2697% | |
| 38.2442% | |
| 29.4253% | |
| 11.6418% | |
| 5.2912% | |
| 6.1786% | |
| 5.4971% | |
| 12.2709% | |
| 15.2979% | |
| 17.5743% | |
| 17.9957% | |
| 13.2913% | |
| 10.2354% | |
| 6.4966% | |
| 4.5539% | |
| 4.0564% | |
| 7.1105% | |
| 5.349% | |
| 2.9535% | |
| -1.4017% | |
| -10.7882% | |
| -8.1093% | |
| -4.5464% | |
| 3.469% | |
| 15.8284% | |
| 38.3422% | |
| 74.6662% | |
| 133.9158% | |
| 235.6176% | |
| 206.3144% | |
| 141.743% | |
| 84.8421% | |
| 30.9315% | |
| 30.6039% | |
| 39.2815% | |
| 33.6548% | |
| 26.3198% | |
| 14.1621% | |
| 11.7609% | |
| 13.9184% | |
| 15.4803% | |
| 22.9057% | |
| 13.4959% | |
| 16.54% | |
| 13.5796% | |
| 10.9931% | |
| 13.7165% | |
| -2.0195% | |
| -8.231% | |
| -12.1856% | |
| -11.4317% | |
| -9.7399% | |
| -4.0054% | |
| 19.9435% |